SUMMARY A prospective study was made of sequential changes in serum creatine kinase (CK) and CK-MB isoenzyme activity within the 12 hours following admission to the coronary care unit on 65 patients with recent chest pain. CK determinations were performed in the laboratory or in the coronary care unit using a dry reagent strip analyser. Slope values for log CK/hour and log CK-MB/ hour were calculated, used to confirm or exclude the diagnosis of myocardial infarction, and compared with diagnosis by conventional means. Compared with retrospective diagnosis using all available information, the CK slope had a sensitivity of 100% and a specificity of 94%. This compared with a sensitivity of 94% and specificity of 90% for diagnosis using upper reference limits alone. Determination of CK slope permits very rapid and accurate biochemical confirmation or exclusion of myocardial infarction and the possibility of performing the measurements on the coronary care unit. It additionally offers the prospect of major cost savings resulting from early discharge or transfer from the coronary care unit.
The exclusion of acute myocardial infarction remains a problem in the patient presenting with acute chest pain. The electrocardiogram (ECG) is commonly used for diagnosis, but ECG changes may be equivocal or obscured by dysrythmias or bundle branch block. An estimated 56% of diagnoses of myocardial infarction require confirmation by some other investigation, typically a "cardiac enzyme" profile.' The conventional strategy of measurement of "cardiac enzymes" on consecutive days following admission, however, will frequently result in unnecessary hospital stay before diagnosis is confirmed or excluded, because 53-74% of the admissions to the coronary care unit may not have acute myocardial infarction. 2' We have previously shown that sequential changes in the logarithm of creatine kinase (CK) activity and its MB isoenzyme (CK-MB) activity in the 12 hours following admission (CK and CK-MB slope) can be used to confirm or exclude the diagnosis ofmyocardial infarction in patients with acute chest pain. 5 We report on the results of a more extended prospective study of Accepted for publication 12 June 1989 this technique and its use in "near-patient" testing for the definitive diagnosis of myocardial infarction in coronary care unit.
Material and methods
Blood samples were obtained on admission and four, eight, and 12 hours later from consecutive patients admitted to the coronary care unit over four months.
Sera were separated and stored frozen at -20°C until analysed for total CK and CK-MB (CK-2) activity.
All samples were analysed within one week of collection.
All patients were assessed by clinical examination and serial electrocardiography. The cardiac enzyme protocol in use in the laboratory (measurement of aspartate transaminase (AST) and hydroxybutyrate dehydrogenase (HBD) for three consecutive days after admission) was also followed. This is referred to as the "standard" enzymes. Full clinical details were recorded prospectively on each patient by proforma.
AST and HBD were measured at 30°C by optimised methods6 with commercially supplied reagents Diagnosis ofacute myocardial infarction (Merckotest GOT(ASAT), Merckotest HBDH, BDH Diagnostics, Poole, Dorset). Total CK was measured at 30°C by an optimised method6 and CK-MB at 30°C by immunoinhibition, both using commercially supplied reagents (CK NAC opt., CK-MB NAC opt., BCL, Lewes, Sussex). All determinations were made using a centrifugal analyser (Encore, Baker Instruments, Windsor, Berkshire). CK was also measured using a dry strip method on the Ames Seralyser (Ames Laboratories, Stoke Poges) on the coronary care unit by a member of the staff. This analyser had been previously assessed for precision and accuracy over the analytical range used.'
All clinical records, electrocardiograms, and changes in the standard enzymes were retrospectively reviewed and a final diagnostic classification produced. Results of echocardiography, gated pool studies of technetium m99 multiple uptake, stress electrocardiography, and 12 lead ECG from previous hospital attendance and at follow up were used, where available. Infarction was judged to have occurred in patients with a history of chest pain accompanied by the development of Q waves, or ischaemic ECG changes and sudden death within 72 hours of admission. S-T and T wave changes were taken to indicate infarction if there were typical changes in "standard" cardiac enzymes or evidence from cardiac imaging. Persistent residual S-T depression or T wave changes without changes in "standard" enzymes were classified as ischaemia ?infarction. Angina was diagnosed in patients with clinical features suggestive of ischaemic heart disease but without "standard" enzyme changes, transient S-T changes, or a positive stress ECG. Crescendo angina was diagnosed when ECG and "standard" enzymes intially indicated ischaemia alone in a patient with persistent pain but changes typical of myocardial infarction occurred 48 hours after admission. Non-ischaemic chest pain was diagnosed when angina could be excluded by a definite alternative source of the chest pain or an atypical history with a negative stress ECG. Information from changes in CK and CK-MB in the serial samples was not used in this classification.
In patients presenting with chest pain of onset within the previous 12 hours CK and CK-MB slope were calculated, as previously described,5 from CK and CK-MB values obtained from the sequential serum samples. Classification into infarct and non-infarct groups was performed using the CK and CK-MB slope values obtained from the previous study (log enzyme change with time, CK or CK-MB slope is independent of assay temperature for optimised methods). Patients with slope values exceeding 0-015 were classified as slope positive, indicative of recent myocardial infarction.
Enzyme diagnosis of infarction in these serial 1127 samples using conventional upper reference limits was also examined. These upper reference limits were: CK 120 U/1, CK-MB 12 U/1, and greater than 5% of the total activity.
Results
Sixty five patients presented with symptoms of less than 12 hours' duration (53 men, 12 women), age range 40-86 years, median 63 years. Using the criteria defined above, 34 patients were considered to have sustained myocardial infarction, five to have had ischaemia ?infarction, one to have had crescendo angina, 15 to have had angina and 10 to have had nonischaemic chest pain. Measurement of CK-MB rather than measurement of CK is advocated on the grounds of specificity. We 1129 found that CK-MB slope failed to reach the discriminant level in one case ofmyocardial infarction because the peak CK-MB value occurred before completion of sampling. This is a reflection of the narrow time window for rise in CK-MB, a criticism of the use of CK-MB for diagnosis of acute myocardial infarction made by other workers." Two patients in the ischaemia ?infarction group had a positive CK slope diagnosis unconfirmed by a CK-MB slope diagnosis. One patient presented with acute left ventricular failure and was clinically suspected to have had acute myocardial infarction. This patient subsequently had a cardiac arrest and died while in hospital. The other patient showed septal akinesia on echocardiography and had residual T wave changes. The CK changes in these patients may represent severe ischaemia alone, but failure to detect CK-MB may have been due to inadequacy of immunoinhibition as an analytical method as in both cases the CK values were low and within the reference interval. In our previous study no problems were seen at comparable levels of total CK, but sensitive, specific methods were used.
The data in our study did not show any improvement in diagnostic performance of CK-MB slope over total CK slope in patients with definite infarction. Release ofCK-MM from damaged skeletal muscle might mimic myocardial infarction. This could cause problems in patients presenting with chest pain following muscle trauma such as intramuscular injection or operation if CK slope alone is used. This did not apply to our patients. In all but two cases the magnitude of the CK-MB slope was equal to or exceeded that of the total CK slope. This would probably not be the case in muscle damage where predominantly CK-MM is released. It would be expected that the value for total CK slope would exceed considerably the value for CK-MB slope: hence measurement of CK-MB slope would establish the diagnosis if this was a potential diagnostic problem.
On the basis of our findings the optimal diagnostic strategy would be to use CK slope for the patient presenting with chest pain, with measurement of CK-MB if an alternative source of CK is suspected (fig 4) . The results obtained with determination of CK using the Seralyser on the coronary care unit were the same as the laboratory results. Hence measurement of CK could be carried out on the coronary care unit, leading to early decisions on treatment or discharge. Prompt diagnosis is helped by a suitable program to calculate slope. We have developed such a program for use on a microcomputer or programmable calculator. This could be integrated with a laboratory computer system to produce an automated interpretive report.
False positive and false negative results were obtained when the diagnosis was made using reference limits. Analysis of the data showed that CK slope had 
